High-Dose Selenium Induces Ferroptotic Cell Death in Ovarian Cancer
International Journal of Molecular Sciences · 18.01.2023 · 24 (3) · 1918
DOI: 10.3390/ijms24031918 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 18.01.2023. Verfasst von Jung-A Choi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul 03722, Republic of Korea. Hauptthemen laut MEDLINE: Selenium, Ovarian Neoplasms. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Korea Healthcare Technology R&D Project, and Ministry for Health and Welfare Affairs, Huons Co., Ltd., Biosynkorea Co., Ltd..
Abstract (Originalsprache)
Selenium is a promising multi-target chemotherapeutic agent with controversial clinical results. Hence, reassessing the anticancer effects of Se is necessary to clearly understand the potential of high-dose selenium in cancer treatment. Here, we observed that high-dose sodium selenite (SS) significantly decreased the proliferation and increased the death of ovarian cancer cells, mediated by an increased generation of reactive oxygen species. Notably, high-dose SS decreased the levels of glutathione peroxidase (GPx), a selenoprotein with antioxidant properties, without altering other selenoproteins. Furthermore, high-dose SS triggered lipid peroxidation and ferroptosis, a type of iron-dependent cell death, due to dysregulated GPx4 pathways. We demonstrated that intravenous high-dose SS significantly reduced the tumor growth and weight in SKOV3-bearing mice. Consistent with our in vitro results, mice with SKOV3 cells treated with high-dose SS showed decreased GPx4 expression in tumors. Therefore, we highlight the significance of high-dose SS as a potential chemotherapeutic agent for ovarian cancer. High-dose SS-mediated ferroptotic therapy integrating glutathione depletion and ROS generation is a promising strategy for cancer therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.
ORCID-Profile: Hanbyoul Cho, Jae-Hoon Kim
Förderung
- the Korea Healthcare Technology R&D Project, and Ministry for Health and Welfare Affairs
- Huons Co., Ltd.
- Biosynkorea Co., Ltd.
- Korea Healthcare Technology R&D Project
- Ministry for Health and Welfare Affairs, Korea
Zitieren
APA
Choi, J. A., Lee, E. H., Cho, H., & Kim, J. H. (2023). High-Dose Selenium Induces Ferroptotic Cell Death in Ovarian Cancer. International Journal of Molecular Sciences, 24(3), 1918. https://doi.org/10.3390/ijms24031918
Vancouver
Choi JA, Lee EH, Cho H, Kim JH. High-Dose Selenium Induces Ferroptotic Cell Death in Ovarian Cancer. International Journal of Molecular Sciences. 2023;24(3):1918. doi:10.3390/ijms24031918
BibTeX
@article{Choi2023,
author = {Choi, Jung-A and Lee, Elizabeth Hyeji and Cho, Hanbyoul and Kim, Jae-Hoon},
title = {High-Dose Selenium Induces Ferroptotic Cell Death in Ovarian Cancer},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {3},
pages = {1918},
doi = {10.3390/ijms24031918}
}
EUVIMED